The first season of the “Kidneys Talk”, a live channel organised by the Hong Kong Kidney Foundation (HKKF), with the Hong Kong Society of Nephrology (HKSN) and the Hong Kong Association of Renal Nurses (HKARN) as the co-organisers, has b...

Early Blood Glucose Control as the Key to Preventing and Delaying Progression DM is the leading cause of CKD worldwide. The Hong Kong Central Renal Registry reported that diabetic nephropathy (DN) accounts for nearly 50% of patients who undergo dial...

Local Burden of CKD Although a CKD registry is currently not available in Hong Kong, the CKD burden can be reflected by the ESRD burden captured by the Hong Kong Renal Registry, which is a systematic online system developed in 1995 by the Hospital A...

Dietary Management of Metabolic Acidosis in Chronic Kidney Disease Metabolic acidosis is an acid-base disorder common in patients with chronic kidney disease (CKD) when the glomerular filtration rate (GFR) falls below 30-40 mL/min/1.73 m 2 1,2 . It ...

The 35 th Anniversary of Hong Kong Peritoneal Dialysis First Policy The health burden of end-stage renal disease (ESRD) is substantial and has been increasing gradually in Hong Kong, whereas dialysis is the lifeline for the majority of patients with...

Finerenone, a selective mineralocorticoid receptor antagonist, has been proven to reduce albuminuria in patients with chronic kidney disease (CKD) and type 2 diabetes in previous trials. Recently, a clinical trial reported the long-term effects of f...

Evaluating Clinical Data in Renal Impaired Subgroup Former meta-analysis demonstrated that the use of NOACs, i.e. rivaroxaban, edoxaban, dabigatran and apixaban, was associated with reduced risk of stroke and systemic embolism (SE) and reduced risk ...

Pathological Bases for Coexistence of CKD and AF Dr. Wang explained that CKD and AF may frequently co-exist in a patient. The 2 disorders share many common risk factors including hypertension, diabetes mellitus (DM), ischaemic heart disease, heart f...

On-treatment Case Patient 1 was a 45-year-old woman who had a strong family history of ADPKD. Her mother and affected maternal relatives started to receive dialysis in their fifties. Polycystic liver was also present. Over a year’s monitoring,...